An Experimental Study on the Effect of Tenofovir Amibufenamide on Blood Lipid During Anti-HBV Treatment

Conditions:   Hepatitis B, Chronic;   Lipid Disorder Interventions:   Drug: oral Tenofovir Amibufenamide 25mg each day;   Drug: lipid lowering drugs (e.g. Atorvastatin and amlodipine.) Sponsor:   Wuhan Union Hospital, China Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials